At a glance
Findings from viral hepatitis related projects were presented at a variety of scientific conferences. These activities inform and improve the effectiveness of public health programs and activities through the NCHHSTP Epidemiologic and Economic Modeling Agreements (NEEMA).
Viral hepatitis abstracts
Zhu L, Pramanick T, Thompson WW, Furukawa NW, Randall LM, Linas BP, Salomon JA. Hepatitis C virus (HCV) screening policies among people who inject drugs (PWID) towards the elimination of hepatitis C. Society for Medical Decision Making (SMDM) 2022.
Zhu L, Havens JR, Rudolph AE, Young AM, Eftekhari G, Thompson WW, Hagan L, Randall LM, Linas BP, Salomon JA. An Agent-Based Network Model of Hepatitis C Virus Transmission Among People Who Inject Drugs Calibrated to a High-Burden Rural Population in the United States. Poster presented at: The 41st Annual Meeting of the Society for Medical Decision Making; October 20-23, 2019. Portland, OR.
Assoumou S, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers During the Opioid Epidemic. Poster presented at: IDWeek Conference; October 2-6, 2019. Washington DC.
Rosenberg ES, Rosenthal EM, Hall EW, Barker L, Hofmeister MG, Sullivan PS, Dietz P, Mermin J, Ryerson AB. Prevalence of chronic hepatitis C virus infection, US States and District of Columbia, 2013-2016. Paper presented at: The Liver Meeting; November 9-13, 2018; San Francisco, CA.
Epstein RL, Wang J, Mayer KH, Puro J, Horsburgh CR, Linas BP, Assoumou SA. HCV Screening Practices Among Adolescents and Young Adults in a National Sample of Federally Qualified Health Centers in the U.S. Abstract accepted at: IDWeek 2018TM, October 3-7, 2018; San Francisco, CA.
Assoumou SA, Tasillo A, Vellozzi CJ, Eftekhari G, Wang J, Nolen S, Hagan L, Thompson W, Strick L, Salomon JA, Linas BP. Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons. Abstract accepted at: The 7th Annual Symposium, Boston University Clinical & Translational Science Institute; May 3th, 2018; Boston, MA.
Assoumou SA, Wang J, Tasillo A, Eftekhari G, Tsui JI, Hariri SH, Velozzi CJ, Strick L, Linas BP. Hepatitis C Testing Strategies in a Correctional Setting. Poster presented at: IDWeek 2017; October 4-8, 2017; San Diego, CA.
Mirzazadeh A, Coffin PO, Goldhaber-Fiebert J, Teshale EH, Gabriela Paz-Bailey G, Asher A, Broz D, Nerlander L, Van Handel M, Rose, CE, McCabe D, Kahn JG. Opioid use and injection prevalence and trends in the United States and two selected states, 2002-2014. Poster presented at: 11th International Congress on the Addiction Science; Sep 15-17, 2017; Tehran, Iran.
Epstein R, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Isenhour C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C: Whom are we screening? Poster presented at: Pediatric Academic Societies Meeting; May 6th-9th, 2-17; San Francisco, CA.
Barocas JA, Tasillo A, Yazdi GE, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Salomon JA, Linas BP. Population level outcomes and cost-effectiveness of expanding guidance for age-based hepatitis C testing in the U.S. Poster presented at: EASL International Liver Congress; April 19th-23rd, 2017; Amsterdam, The Netherlands.
Hall E, Rosenberg ES. Assessing the cost-effectiveness of a single-dose hepatitis B revaccination among infants not responding to the initial vaccine series and born to hepatitis B-infected mothers. Paper presented to: The Advisory Committee on Immunization Practices; February 22, 2017; Atlanta, GA.